Aeterna Zentaris to Present at the 2nd Annual Disruptive Growth & Healthcare Conference
February 09 2017 - 8:30AM
Business Wire
Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the “Company”),
announced today that it will be presenting at the 2nd Annual
Disruptive Growth & Healthcare Conference on Thursday,
February 16 at 9:30 AM EST. President and Chief Executive Officer,
Mr. David A. Dodd will be presenting an updated overview of the
Company, as well as meeting with investors.
Participants may access the live webcast via the Company’s
website at www.aezsinc.com. A replay of the webcast will also be
available on the Company’s website approximately one hour following
the live webcast.
The 2017 Disruptive Growth & Healthcare Conference will
offer the exclusive opportunity to discover life science companies
focusing on solutions to unmet medical needs and growth companies
with disruptive technologies and business models.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel treatments in
oncology and endocrinology. We are engaged in drug development
activities and in the promotion of products for others. We are now
conducting Phase 3 studies of two internally developed compounds.
The focus of our business development efforts is the acquisition or
in-license of products that are relevant to our therapeutic areas
of focus. We also intend to license out certain commercial rights
of internally developed products to licensees in territories where
such out-licensing would enable us to ensure development,
registration and launch of our product candidates. Our goal is to
become a growth-oriented specialty biopharmaceutical company by
pursuing successful development and commercialization of our
product portfolio, achieving successful commercial presence and
growth, while consistently delivering value to our shareholders,
employees and the medical providers and patients who will benefit
from our products. For more information, visit www.aezsinc.com.
For those interested in attending, please visit
www.DisruptNYC.com for more information.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170209005127/en/
Aeterna Zentaris Inc.Philip A. Theodore, Senior Vice
PresidentIR@aezsinc.com843-900-3223
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Apr 2023 to Apr 2024